Neuroprotective Effects of Genome-Edited Human iPS Cell-Derived Neural Stem/Progenitor Cells on Traumatic Brain Injury.

Authors:
Imai R; Tamura R; Yo M; Sato M; Fukumura M and 4 more

Journal:
Stem Cells

Publication Year: 2023

DOI:
10.1093/stmcls/sxad028

PMCID:
PMC10267696

PMID:
37029780

Journal Information

Full Title: Stem Cells

Abbreviation: Stem Cells

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cell Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data availability rna-seq data have been deposited in the ncbi gene expression omnibus (geo) under accession number gse150470. data availability rna-seq data have been deposited in the ncbi gene expression omnibus (geo) under accession number gse150470"

Code Sharing
Evidence found in paper:

"Conflict of Interest H.O. is a compensated scientific consultant of San Bio, Co., Ltd. and K Pharma Inc. and an inventor on patents related to genome-edited iPSCs. M.T. is a founding scientist of iXgene Inc. and an inventor of patents related to genome-edited iPSCs. The other authors declare no potential conflicts of interest."

Evidence found in paper:

"Funding This work was partly supported by grants from the Japan Society for the Promotion of Science (16K20026 to R.T., 17H04306 and 18K19622 to M.T.) and Japan Agency for Medical Research and Development (JP19am0401015 and JP18lm0203004 to M.T.)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025